Bente Vilsen

Prof. Dr. Bente Vilsen

orcid

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2007 in Nature
Verified
Journal Article
Closed access
PDF file
JMJ. Preben Morth
J. Preben Morth
BPBjørn P. Pedersen
Bjørn P. Pedersen
MTMads Schak Toustrup-Jensen
Mads Schak Toustrup-Jensen
TSThomas L.-M. Sørensen
Thomas L.-M. Sørensen
JPJanne Petersen
Janne Petersen
PNPoul Nissen
Poul Nissen

17 February 2013 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
FBFelix Beuschlein
Felix Beuschlein
Sheerazed BoulkrounSheerazed Boulkroun
Sheerazed Boulkroun
AOAndrea Osswald
Andrea Osswald
TWThomas Wieland
Thomas Wieland
HNHang N Nielsen
Hang N Nielsen
MRMartin Reincke
Martin Reincke

22 December 2010 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
JMJ. Preben Morth
J. Preben Morth
BPBjørn P. Pedersen
Bjørn P. Pedersen
MBMorten J. Buch-Pedersen
Morten J. Buch-Pedersen
JAJens Peter Andersen
Jens Peter Andersen
BVBente Vilsen
Bente Vilsen
PNPoul Nissen
Poul Nissen

2 October 2013 in Nature
Verified
Journal Article
Closed access
RKRyuta Kanai
Ryuta Kanai
HOHaruo Ogawa
Haruo Ogawa
BVBente Vilsen
Bente Vilsen
FCFlemming Cornelius
Flemming Cornelius
CTChikashi Toyoshima
Chikashi Toyoshima

1 May 2014 in The Lancet Neurology
Verified
Journal Article
Closed access
EHErin L Heinzen
Erin L Heinzen
AAAlexis Arzimanoglou
Alexis Arzimanoglou
ABAllison Brashear
Allison Brashear
SCSteven J Clapcote
Steven J Clapcote
FIORELLA GURRIERIFIORELLA GURRIERI
FIORELLA GURRIERI
BVBente Vilsen
Bente Vilsen

18 August 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SCSteven J. Clapcote
Steven J. Clapcote
SDSteven Duffy
Steven Duffy
GXGang Xie
Gang Xie
GKGreer Kirshenbaum
Greer Kirshenbaum
ABAllison R. Bechard
Allison R. Bechard
JRJohn C. Roder
John C. Roder
In a mouse mutagenesis screen, we isolated a mutant, Myshkin ( Myk ), with autosomal dominant complex partial and secondarily generalized seizures, a greatly reduced threshold for hippocampal seizures in vitro, posttetanic hyperexcitability of the CA3-CA1 hippocampal pathway, and neuronal degeneration in the hippocampus. Positional cloning and functional analysis revealed that Myk /+ mice carry a mutation (I810N) which renders the normally expressed Na + ,K + -ATPase α3 isoform inactive. Total Na + ,K + -ATPase activity was reduced by 42% in Myk /+ brain. The epilepsy in Myk /+ mice and in vitro hyperexcitability could be prevented by delivery of additional copies of wild-type Na + ,K + -ATPase α3 by transgenesis, which also rescued Na + ,K + -ATPase activity. Our findings reveal the functional significance of the Na + ,K + -ATPase α3 isoform in the control of epileptiform activity and seizure behavior.